DexCom

BalançosDexCom

DXCM

A Dexcom projeta e comercializa monitores contínuos de glicose para diabéticos. Os sistemas CGM são uma alternativa ao processo tradicional de medição de glicose no sangue, e a empresa está evoluindo para integrar as bombas de insulina da Insulet e Tandem para entrega automática de insulina.

Tabela de balanços completa e atualizada com os principais indicadores financeiros: Lucro Líquido, Receita, EBTIDA, Margem, ROE, Dividendos

Ano
12/2016
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2017
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2018
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2019
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2020
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
$1,345
12/2021
2,449
368
012
9%
0.51
2,042
11%
-749
-
329
-389
10
-60
0
0
-
-
12/2022
2,910
547
012
12%
0.8
2,132
16%
-1,258
-
543
-365
-552
178
-558
0
-
-
12/2023
3,622
784
012
15%
1.3
2,069
26%
-290
-
598
-237
-319
361
-689
0
-
-
12/2024
4,033
818
012
14%
1.4
2,103
27%
-1,342
-
819
-359
-735
460
-750
0
-
-
12/2025
4,662
1,164
012
18%
2.1
2,746
30%
-758
-
1,281
-363
-1,686
918
-500
0
-
-